Quanterix Corporation (Nasdaq: QTRX), relating to the proposed merger with Akoya Biosciences. Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Quanterix shareholders will own approximately 70% of the combined company.